Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CE-mark for RayMedica's PDN (prosthetic disc nucleus):

This article was originally published in Clinica

Executive Summary

RayMedica has CE-marked its prosthetic disc nucleus, designed for treating degenerative disc disease which results in chronic and debilitating back pain. The tiny pillow-shaped device is intended as an alternative to a discectomy, the removal of the spinal disc, and is implanted inside the degenerating disc. It restores the disc's ability to separate the bones of the spine and act as a shock absorber, relieving pressure on nearby nerves. The company has carried out clinical studies on its device in five countries including the US.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts